April 18, 2011 (San Diego, California) — Nearly 50% of patients receiving a left ventricular assist device (LVAD) experience a hospital readmission within 6 months of implantation, and most first-time ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Fraunhofer IOF, startup NovaPump, and Jena University Hospital’s “pump cage” is cut out of a thin metal tube by laser. On the occasion of World Heart Day on September 29, the team reviewed the history ...
The search for the perfect artificial heart seems never-ending. After decades of trial and error, surgeons remain stymied in their quest for a machine that does not wear out, break down or cause clots ...
HEARTROID PROJECT HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID® platform, a catheter-based simulator, will participate in TTDD lab's effort of validating ...
HEARTROID PROJECT and the TTDD lab at MIT today announced a creative partnership. HEARTROID ® platform, a catheter-based simulator, will participate in TTDD lab's effort of validating device ...
BORDEAUX, France--(BUSINESS WIRE)--FineHeart, SA, a preclinical-stage medical device company developing an Implantable Cardiac Output Management System (ICOMS) to address the unmet need of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback